Search Results

This webinar provides an assessment of recent job market activity across biopharma and explores how companies approaching commercial readiness or building out sales and marketing teams can navigate today’s hiring trends.

DIA’s 2026 Latin America Annual Meeting brings together key stakeholders to advance life sciences R&D across Latin America and the Caribbean. Expanded Regulatory/Clinical and Safety/Pharmacovigilance tracks — plus new cross-track sessions and hands-on workshops — foster collaboration and real-world knowledge exchange, with medical devices woven throughout the agenda. Join the conversation on multi-regional cooperation, global harmonization, and best practices shaping the future of healthcare in the region.

Summit Therapeutics and Akeso are answering questions raised about ivonescimab’s ability to translate to Western populations, though the partners have yet to share if the new findings are statistically significant.

With Phase 3 data showing what analysts called a “potentially best-in-class profile,” Arrowhead Pharmaceuticals plans to submit for FDA approval of plozasiran by the end of the year—hoping to follow to market Ionis Pharmaceuticals’ Tryngolza, which got the regulator’s nod in severe hypertriglyceridemia last month.

Top-selling cell therapies from BMS, J&J and Gilead depend on a BioLife product, positioning Repligen to use the takeover to increase its exposure to the modality.

Looking for a biopharma job in Cambridge? Roles posted on BioSpace have more than doubled compared to last year.